| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.08 | 0.6 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |